Search
-
Learn how we continue to check in after your active treatment for mesothelioma is done. We want to be sure that you’re healing well and managing any pain or other side effects.
… Follow-up care after treatment for mesothelioma at Memorial Sloan Kettering is very important for helping you live longer and healthier. The experts who helped treat you for mesothelioma will take care of you for the first two to three years after treatment. For example, you may find that managing symptoms
-
Learn about common signs and symptoms of endometrial (uterine) cancer which include abnormal vaginal bleeding and heavy bleeding between periods.
… More than 90 percent of women with endometrial (uterine) cancer experience abnormal vaginal bleeding . In some cases, the bleeding may appear as vaginal discharge that is watery, pink, or white instead of red. Women in their late 30s and early 40s may also experience heavy bleeding between periods. If
-
Rare Blood Disorders
Our medical team has unparalleled expertise in diagnosing uncommon blood disorders. We provide state-of the-art treatment for these diseases and their complications.
… Our experts in rare blood disorders have unparalleled expertise in diagnosing uncommon blood disorders such as myeloproliferative neoplasms . We provide state-of the-art treatment for these diseases and their complications. Select from the list below to learn more about our specialists, their education
-
Explore the many ways that MSK can help you physically, emotionally, spiritually, and otherwise once treatment for gallbladder cancer ends.
… At Memorial Sloan Kettering, we know that even after you’ve finished gallbladder cancer treatments, you may still need our help. We’re committed to supporting you in every way we can — physically, emotionally, spiritually, and otherwise — for as long as you need us. We’ve built a program designed for
-
After someone has had gastroesophageal reflux disease for many years, it can advance to Barrett’s esophagus, a condition that greatly increases the risk of developing cancer.
… After someone has had gastroesophageal reflux disease (GERD) for many years, it can advance to Barrett’s esophagus. Barrett’s is a way the esophagus defends itself: The cells in the lining of the esophagus start to change because they’ve been exposed to acid for many years. Barrett’s esophagus is considered
-
Soft Tissue Sarcoma
Meet MSK's team of soft tissue sarcoma doctors, surgeons, radiation oncologists, and other specialists who provide comprehensive, personalized care for people with soft tissue sarcoma.
… Memorial Sloan Kettering is home to a team of compassionate doctors and other experts from different areas who specialize in treating soft tissue sarcoma. This includes surgeons, medical oncologists, radiation oncologists, pathologists, radiologists, and highly trained nurses. All of the healthcare professionals
-
Find out how we classify the many types of lymphoma, including Hodgkin and non-Hodgkin lymphoma.
… There are more than 70 different types of lymphoma. They range from indolent (slow growing) to highly aggressive. Lymphomas are categorized into two broad groups: non-Hodgkin lymphoma and Hodgkin lymphoma. Both types can occur in either children or adults. Most lymphomas arise from the two main types
-
Multiple Myeloma
MSK is a major research institution. During your treatment for multiple myeloma, your care team may ask if you want to join a clinical trial.
… MSK is a major research institution. During your treatment for multiple myeloma, your care team may ask if you want to join a clinical trial. What is a clinical trial? Clinical trials are research studies that test new treatments, procedures, or devices to see how well they work. They are an important
-
Male Breast Cancer
Male breast cancer is rare, but our researchers are conducting research aimed specifically at treating men with this disease.
… Historically, treatment for male breast cancer has been adapted from what we learn about research looking at breast cancer in women. But thanks in part to new studies that have found molecular differences between breast cancers in men and women, our clinical investigators are beginning to study the unique